Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01734668 · ClinicalTrials.gov registry record
Sofia RSV FIA Field Study
A clinical trial, sponsored by Quidel Corporation.
- Completed
- Registry status
- 2,468
- Enrollment target
NCT01734668 is a clinical trial that has completed, run by Quidel Corporation. The registered enrollment target is 2,468 participants.
The verdict
NCT01734668 has completed, sponsored by Quidel Corporation.
- COMPLETED
- Registry status
- 2,468 participants
- Enrollment target
Study Summary
The objective of this study is to demonstrate the clinical performance of the Sofia RSV FIA with specimens from symptomatic pediatric subjects who are less than nineteen (19) years of age.
Interventions
- DEVICE In Vitro Diagnostic device to aid in diagnosis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,468 participants |
| Start Date | 2012-03 |
| Est. Completion | 2013-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01734668
The ClinicalTrials.gov registry entry for NCT01734668 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 2,468 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Quidel Corporation, which has 9 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which In Vitro Diagnostic device to aid in diagnosis is the first listed.
NCT01734668 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01734668 about?
NCT01734668 is a clinical study titled "Sofia RSV FIA Field Study". The objective of this study is to demonstrate the clinical performance of the Sofia RSV FIA with specimens from symptomatic pediatric subjects who are less than nineteen (19) years of age.
What is the current status of trial NCT01734668?
This trial is currently completed. The enrollment target is 2,468 participants. The study started on 2012-03. Estimated completion is 2013-01.
What interventions are being tested in trial NCT01734668?
The interventions under investigation include: In Vitro Diagnostic device to aid in diagnosis (DEVICE).
Who is sponsoring clinical trial NCT01734668?
This trial is sponsored by Quidel Corporation, which has 9 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.